Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Atkins

Showing results (681-690 of 694) with videos related to

Pageof 70
Sort By:
Journal of the National Cancer Institute|March 21, 2022
Quantitative Nodal Burden and Mortality Across Solid CancersAnthony T Nguyen, Michael Luu, Vina P Nguyen, et al.
Cancer Medicine|May 14, 2025
Subclinical Atherosclerosis and Cardiovascular Events Among Patients With Colorectal CancerJulia A Levy, Elham Kazemian, Cody Ramin, et al.
Science Translational Medicine|June 3, 2011
A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinomaNatsuko Suwaki, Elsa Vanhecke, Katelyn M Atkins, et al.
Annals of Internal Medicine|April 15, 1997
The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies To Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial InfarctionK Dracup, A A Alonzo, J M Atkins, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 18, 2004
A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much?S L Taylor, S L Hefle, C Bindslev-Jensen, et al.
American Heart Journal|March 20, 2012
Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical servicesHarry P Selker, Joni R Beshansky, John L Griffith, et al.
Blood|December 9, 2024
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomesCiara L Freeman, Jerald Noble, Meghan Menges, et al.
The American Journal of Cardiology|May 6, 2014
One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial)Harry P Selker, James E Udelson, Joseph M Massaro, et al.
JAMA|March 29, 2012
Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trialHarry P Selker, Joni R Beshansky, Patricia R Sheehan, et al.
BMC Cancer|April 4, 2023
Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomesCaroline Himbert, Jennifer Ose, Biljana Gigic, et al.
Pageof 70

Showing results (681-690 of 694) with videos related to

Sort By:
Pageof 70
Journal of the National Cancer Institute|March 21, 2022
Quantitative Nodal Burden and Mortality Across Solid CancersAnthony T Nguyen, Michael Luu, Vina P Nguyen, et al.
Cancer Medicine|May 14, 2025
Subclinical Atherosclerosis and Cardiovascular Events Among Patients With Colorectal CancerJulia A Levy, Elham Kazemian, Cody Ramin, et al.
Science Translational Medicine|June 3, 2011
A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinomaNatsuko Suwaki, Elsa Vanhecke, Katelyn M Atkins, et al.
Annals of Internal Medicine|April 15, 1997
The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies To Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial InfarctionK Dracup, A A Alonzo, J M Atkins, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 18, 2004
A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much?S L Taylor, S L Hefle, C Bindslev-Jensen, et al.
American Heart Journal|March 20, 2012
Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical servicesHarry P Selker, Joni R Beshansky, John L Griffith, et al.
Blood|December 9, 2024
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomesCiara L Freeman, Jerald Noble, Meghan Menges, et al.
The American Journal of Cardiology|May 6, 2014
One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial)Harry P Selker, James E Udelson, Joseph M Massaro, et al.
JAMA|March 29, 2012
Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trialHarry P Selker, Joni R Beshansky, Patricia R Sheehan, et al.
BMC Cancer|April 4, 2023
Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomesCaroline Himbert, Jennifer Ose, Biljana Gigic, et al.
Pageof 70